DK0754682T3 - Aminostilbazolderivat og lægemiddel - Google Patents

Aminostilbazolderivat og lægemiddel

Info

Publication number
DK0754682T3
DK0754682T3 DK95914513T DK95914513T DK0754682T3 DK 0754682 T3 DK0754682 T3 DK 0754682T3 DK 95914513 T DK95914513 T DK 95914513T DK 95914513 T DK95914513 T DK 95914513T DK 0754682 T3 DK0754682 T3 DK 0754682T3
Authority
DK
Denmark
Prior art keywords
represents hydrogen
drug
hydroxy
ring
substituted
Prior art date
Application number
DK95914513T
Other languages
Danish (da)
English (en)
Inventor
Hiroyoshi Hidaka
Akira Matsuura
Original Assignee
Western Therapeutics Inst D
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Western Therapeutics Inst D, Nippon Shinyaku Co Ltd filed Critical Western Therapeutics Inst D
Application granted granted Critical
Publication of DK0754682T3 publication Critical patent/DK0754682T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
DK95914513T 1994-04-06 1995-04-05 Aminostilbazolderivat og lægemiddel DK0754682T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6825294 1994-04-06
PCT/JP1995/000658 WO1995027699A1 (en) 1994-04-06 1995-04-05 Aminostilbazole derivative and medicine

Publications (1)

Publication Number Publication Date
DK0754682T3 true DK0754682T3 (da) 2002-02-04

Family

ID=13368389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914513T DK0754682T3 (da) 1994-04-06 1995-04-05 Aminostilbazolderivat og lægemiddel

Country Status (14)

Country Link
US (1) US5972976A (show.php)
EP (1) EP0754682B9 (show.php)
JP (1) JP3080405B2 (show.php)
KR (1) KR100293867B1 (show.php)
CN (1) CN1053658C (show.php)
AT (1) ATE207057T1 (show.php)
CA (1) CA2187214C (show.php)
DE (1) DE69523298T2 (show.php)
DK (1) DK0754682T3 (show.php)
ES (1) ES2165911T3 (show.php)
PT (1) PT754682E (show.php)
RU (1) RU2138482C1 (show.php)
TW (1) TW308586B (show.php)
WO (1) WO1995027699A1 (show.php)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2328719A1 (en) * 1998-04-15 1999-10-21 Hiroyoshi Hidaka Method for in vivo detecting target protein gene by drug
ATE366114T1 (de) * 1998-05-12 2007-07-15 Greenville Hospital System Verwendung von anti-prolaktin agentien zur behandlung von krebs
US6994283B1 (en) * 1999-04-23 2006-02-07 Nippon Shinyaku Co., Ltd. Method for pulverizing to fine powder
US6521658B1 (en) 1999-05-28 2003-02-18 Abbott Laboratories Cell proliferation inhibitors
MXPA02005866A (es) * 1999-12-14 2002-10-23 Nippon Shinyaku Co Ltd Derivados de heterociclo y drogas.
JP2004359545A (ja) * 2001-03-08 2004-12-24 D Western Therapeutics Institute 抗癌剤耐性克服剤
KR100801121B1 (ko) * 2001-04-10 2008-02-05 니뽄 신야쿠 가부시키가이샤 만성 관절 류마티즘 치료제
EP1382335A4 (en) 2001-04-26 2006-05-24 Nippon Shinyaku Co Ltd PHARMACEUTICAL PRODUCTS
US6951875B2 (en) * 2001-10-29 2005-10-04 Hoffmann-La Roche Inc. Conjugated aromatic compounds with a pyridine substituent
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
EP1547596A4 (en) * 2002-09-06 2008-11-19 Western Therapeutics Inst Inc MEDICAL COMPOSITION AND METHOD FOR THE TREATMENT OF MALIGNANT TUMORS AND THE USE THEREOF
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
WO2007137196A2 (en) * 2006-05-19 2007-11-29 Threshold Pharmaceuticals, Inc. Tubulin binding anti cancer compounds and prodrugs thereof
US20100198262A1 (en) * 2009-01-30 2010-08-05 Mckinley Laurence M Axial offset bone fastener system
EP2986596A4 (en) * 2013-04-19 2017-02-08 The Board of Trustees of the University of Arkansas Combretastatin analogs
BR122020005031B1 (pt) 2013-12-13 2022-08-02 Eurochem Agro Gmbh Processo para preparação de ácido 2-(n-3,4-dimetilpirazol) succínico e solução alcalina aquosa de ácido 2-(n-3,4-dimetilpirazol) succínico
CA2940694A1 (en) 2014-03-31 2015-10-08 Board Of Trustees Of The University Of Arkansas Disubstituted triazole analogs
DE102017201608A1 (de) 2017-02-01 2018-08-02 Eurochem Agro Gmbh 3,4-Dimethylpyrazol enthaltende Mischung und ihre Verwendung
CN112110829B (zh) * 2019-06-19 2023-08-01 复旦大学 一种能结合α-突触核蛋白聚集体的小分子化合物、其制备方法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129611T2 (de) * 1990-08-20 1998-12-17 Eisai Co., Ltd., Tokio/Tokyo Sulfonamid-Derivate
JP2790926B2 (ja) * 1990-08-20 1998-08-27 エーザイ株式会社 スルホンアミド誘導体
JP2692467B2 (ja) * 1991-12-09 1997-12-17 ダイキン工業株式会社 空調制御装置の電力供給装置
EP0570594B1 (en) * 1991-12-10 1997-07-30 Shionogi & Co., Ltd. Hydroxamic acid derivative based on aromatic sulfonamide

Also Published As

Publication number Publication date
EP0754682A4 (en) 1998-03-04
KR100293867B1 (ko) 2001-09-17
EP0754682B9 (en) 2003-09-17
CA2187214A1 (en) 1995-10-19
CA2187214C (en) 2002-03-12
CN1145066A (zh) 1997-03-12
PT754682E (pt) 2002-03-28
ES2165911T3 (es) 2002-04-01
RU2138482C1 (ru) 1999-09-27
JP3080405B2 (ja) 2000-08-28
WO1995027699A1 (en) 1995-10-19
MX9604540A (es) 1997-09-30
DE69523298T2 (de) 2002-06-27
EP0754682B1 (en) 2001-10-17
EP0754682A1 (en) 1997-01-22
ATE207057T1 (de) 2001-11-15
DE69523298D1 (de) 2001-11-22
KR970702253A (ko) 1997-05-13
TW308586B (show.php) 1997-06-21
US5972976A (en) 1999-10-26
CN1053658C (zh) 2000-06-21

Similar Documents

Publication Publication Date Title
DK0754682T3 (da) Aminostilbazolderivat og lægemiddel
ATE396988T1 (de) Chinolin- und chianzolinderivate zur behandlung von tumoren
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
EA200300982A1 (ru) Гетероциклические производные для лечения рака и других пролиферативных заболеваний
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ATE232528T1 (de) Pyrimidinylpyrazolderivate
ATE324362T1 (de) Neue vinylbenzolderivate
ATE248814T1 (de) 16-ene-vitamin d derivate
MY130817A (en) Herbicides
DE60307792D1 (de) Hydroxylierte indirubinderivate
FI915025A0 (fi) 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE24915T1 (de) Synergistin-derivate und ihre herstellung.
NO951211D0 (no) Ny 7-substituert oksa- eller azasteroidforbindelse
FI935399L (fi) N-substituerade azabicykloheptanderivat samt deras framstaellning och anvaendning